Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Debopam Samanta to Anticonvulsants

This is a "connection" page, showing publications Debopam Samanta has written about Anticonvulsants.

 
Connection Strength
  
 
 
5.548
  
  1. Samanta D. A comprehensive review of evolving treatment strategies for Dravet syndrome: Insights from randomized trials, meta-analyses, real-world evidence, and emerging therapeutic approaches. Epilepsy Behav. 2025 Jan; 162:110171.
    View in: PubMed
    Score: 0.890
  2. Samanta D. Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm. Epilepsy Behav. 2024 Dec; 161:110123.
    View in: PubMed
    Score: 0.885
  3. Sullivan J, Gunning B, Zafar M, Guerrini R, Gecz J, Kolc KL, Zhao Y, Gasior M, Aimetti AA, Samanta D. Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy. Epilepsy Res. 2023 03; 191:107112.
    View in: PubMed
    Score: 0.787
  4. Samanta D. Changing Landscape of Dravet Syndrome Management: An Overview. Neuropediatrics. 2020 04; 51(2):135-145.
    View in: PubMed
    Score: 0.639
  5. Samanta D. Management of Alternating Hemiplegia of Childhood: A Review. Pediatr Neurol. 2020 02; 103:12-20.
    View in: PubMed
    Score: 0.626
  6. Samanta D, Willis E, Sharp GB. Absence status after starting clobazam in a patient with syndrome of continuous spike and wave during slow sleep (CSWS). Neurol India. 2014 Nov-Dec; 62(6):685-7.
    View in: PubMed
    Score: 0.443
  7. Samanta D. Pharmacotherapeutic management of seizures in patients with Angleman Syndrome. Expert Opin Pharmacother. 2022 Sep; 23(13):1511-1522.
    View in: PubMed
    Score: 0.189
  8. Samanta D. Reply to comments on "A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development". Epilepsy Behav. 2022 06; 131(Pt A):108704.
    View in: PubMed
    Score: 0.186
  9. Samanta D. A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development. Epilepsy Behav. 2022 03; 128:108577.
    View in: PubMed
    Score: 0.183
  10. Samanta D. Rescue therapies for seizure emergencies: current and future landscape. Neurol Sci. 2021 Oct; 42(10):4017-4027.
    View in: PubMed
    Score: 0.176
  11. Samanta D. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review. Epilepsy Behav. 2021 01; 114(Pt A):107612.
    View in: PubMed
    Score: 0.168
  12. Samanta D. Epilepsy in Angelman syndrome: A scoping review. Brain Dev. 2021 Jan; 43(1):32-44.
    View in: PubMed
    Score: 0.166
  13. Samanta D, Garrity L, Arya R. Refractory and Super-refractory Status Epilepticus. Indian Pediatr. 2020 03 15; 57(3):239-253.
    View in: PubMed
    Score: 0.161
  14. Yuskaitis CJ, Mytinger JR, Baumer FM, Zhang B, Liu S, Samanta D, Hussain SA, Yozawitz EG, Keator CG, Joshi C, Singh RK, Bhatia S, Bhalla S, Shellhaas R, Harini C. Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms. Neurology. 2022 11 29; 99(22):e2494-e2503.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.